Cancer biomarkers and personalized cancer medicine.
10.3881/j.issn.1000-503X.2015.01.021
- Author:
Xue-lin DOU
1
;
Chun-mei BAI
1
Author Information
1. Department of Medical Oncology, PUMC Hospital, CAMS and PUMC, Beijing 100052, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
Humans;
Neoplasms;
Precision Medicine
- From:
Acta Academiae Medicinae Sinicae
2015;37(1):113-117
- CountryChina
- Language:English
-
Abstract:
The development of cancer biomarkers has brought the treatment of cancer from the tumor type-based to molecular target-based,and the latter marks the introduction of personalized cancer medicine (PCM). However,each individual tumor has unique molecular information,and the real PCM should be focused on single individuals and their specific molecular identities.
